W Health Ventures closes second fund at $80M to build healthcare companies from scratch
What's the deal? W Health VenturesDealroom has a profile for this one. Try Dealroom →, a Mumbai-based healthcare-focused venture capital firm, has closed its second fund at ₹700 crore, beating an initial target of ₹630 crore. It plans to build 8-10 healthcare companies over the next four years.
What's the endgame? Fund II advances the firm's "company creation" model, which builds businesses from the idea stage rather than backing existing startups. An in-house team of physicians, operators, and technologists spends 12-18 months evaluating and de-risking opportunities before recruiting founding teams.
Why now? "India is at an inflection point in healthcare as the rising demand and constrained supply create a structural mismatch. That mismatch is where lasting businesses are built," said managing partner Dr Pankaj Jethwani.
He added that the firm avoids a template approach: "We're not importing a Silicon Valley playbook and hoping it works here."
What's built so far? Fund II has already produced two companies. Everhope Oncology, built with Narayana Health, focuses on patient-centred oncology care; Everbright HealthDealroom has a profile for this one. Try Dealroom → is developing interventions for treatment-resistant depression in the US.
W Health Ventures said its portfolio companies have reached 25 million patients. It runs a 50-member team and targets healthcare problems where it sees scope for first-to-market solutions.
The signal: With Fund II, the firm plans to expand its venture-building approach across India and the US-India corridor, betting that a structural gap between demand and supply will keep producing durable businesses.
Read more: thehindubusinessline.com
Image credit: Generated with Gemini
